Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phentermine for Pediatric Obesity
NCT04678323Phase 3Withdrawn
- Sponsor
- University of Minnesota
- Start
- Jan 2022
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of phentermine in obesity, sponsored by University of Minnesota. Planned start Jan 2022; status: withdrawn.
02
Drugs
phentermine
03
Conditions
obesity
Beyond the preview
Go deeper on NCT04678323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04678323.